PGL 0.00% 44.5¢ prospa group limited.

But there is still more:Febr. 11, 2004: "Today marks the...

  1. 22,691 Posts.
    But there is still more:

    Febr. 11, 2004: "Today marks the beginning of a 90 patient, multicenter Phase II trial of PI-88 in combination with Taxotere® for the second-line treatment of advanced non-small cell lung cancer (NSCLC)".

    So, Phase II Myeloma has been completed and currently there are 2 more Phase II trials going: Melanoma and NSCLC.

    Gerry
 
watchlist Created with Sketch. Add PGL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.